Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Eddingpharm acquires rights to several oncology assets from ACT Biotech

Jan. 10, 2014

Amunix and Janssen extend worldwide collaboration and licensing agreement

Jan. 9, 2014

DURECT grants Impax worldwide rights to develop and commercialize ELADUR pain patch

Jan. 9, 2014

Trovagene and US Oncology Research collaborate on urine-based KRAS testing study

Jan. 9, 2014

Astellas Pharma and ClearPath Development to build vaccine company portfolio

Jan. 9, 2014

Allergan and Medytox close licensing agreement covering neurotoxin product candidates

Jan. 8, 2014

Qiagen launches therascreen IDH1/2 test for gliomas and collaborates with Mayo Clinic

Jan. 8, 2014

Sutro Biopharma and Memorial Sloan-Kettering to produce antibodies for neuroblastoma

Jan. 8, 2014

Ossianix forms research collaboration with Lundbeck

Jan. 8, 2014

Horizon Discovery forms oncology agreement with AstraZeneca

Jan. 8, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...